Major doubts remain as industry reacts to CBD down scheduling by Steve Jones September 10, 2020September 14, 2020 Industry leaders have given a cautious welcome to the interim ruling to down schedule low-dose CBD, […]
The Biz Interview: LeafCann chief executive Elisabetta Faenza by Steve Jones August 19, 2020August 25, 2020
Analysis: why government underfunding is putting Australian medical cannabis users at risk by Steve Jones August 12, 2020August 13, 2020